Sat.Mar 12, 2022 - Fri.Mar 18, 2022

article thumbnail

Will people be left behind by the digital health revolution?

pharmaphorum

The uptake of digital health tools during the pandemic has been enormous due to improved access they provide to healthcare. In this article, Ben Hargreaves asks whether there are gaps in those utilising these solutions and what action is being taken to address this. Digital health has a tremendous capacity to transform the healthcare industry, with the ability to provide easy access to a multitude of services and new types of therapies.

145
145
article thumbnail

Enveric taps University of Calgary to study psychedelic therapy in cancer-related distress

Outsourcing Pharma

The pharma company and academic institution will explore the viability of a psychedelic treatment to help patients suffering from cancer-related distress.

121
121
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

ARTICLE ON FUTURISTIC APPROACH FOR MEDICAL DIAGNOSTICS ; BIOCHIP

Pharma Tutor

ARTICLE ON FUTURISTIC APPROACH FOR MEDICAL DIAGNOSTICS ; BIOCHIP. About Author. Meenu Maurya. Email : meenudinesh15@gmail.com. admin. Wed, 03/16/2022 - 15:06. Tags. Articles.

72
article thumbnail

Omicron BA.2 variant triggers COVID-19 surge in England

Pharma Times

The sub-variant combines mutations from both Omicron and Delta

70
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

AZ, Merck get FDA okay for Lynparza as adjuvant breast cancer therapy

pharmaphorum

The FDA has cleared AstraZeneca and Merck & Co’s Lynparza as an adjuvant or neoadjuvant treatment for breast cancer, extending its lead over pretenders to its PARP inhibitor crown. The new approval is for use in patients with BRCA-mutated, HER2-negative early-stage breast cancer who have already been treated with chemotherapy – either before or after surgery – and are at high risk of the disease coming back.

FDA 140
article thumbnail

Pharma leaders should step up on artificial intelligence: ConcertAI

Outsourcing Pharma

An executive from the AI specialist discusses how recent advances have provided opportunities for industry professionals to champion new ways of thinking.

103
103

More Trending

article thumbnail

NHS mental health referrals has reached record high

Pharma Times

COVID-19 has highlighted another significant widespread problem – the mental health pandemic

62
article thumbnail

Eisai hands off responsibility for Aduhelm to Biogen

pharmaphorum

Japanese pharma Eisai has backed away from its 50:50 profit-sharing arrangement with Biogen for troubled Alzheimer’s therapy Aduhelm, handing over full responsibility to its US counterpart. The changes to the terms of their longstanding collaboration on Aduhelm (aducanumab) means that Eisai’s profit-share converts to a simple royalty rate on revenues from 1 January next year.

Insurance 118
article thumbnail

The right tech can fill gap between lab scientist and data: ACD/Labs

Outsourcing Pharma

An expert from the R&D tech provider discusses how automation, integration, and other tools can help with effective access and analysis of lab information.

98
article thumbnail

Routes into microbiology – how apprenticeships help

Pharmig

Everyone wants to know where they come from, and microbiologists are no different. But were we grown in a petri dish. The post Routes into microbiology – how apprenticeships help appeared first on Pharmig.

52
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Scientists identify two more hybrid variants alongside Deltacron

Pharma Times

The hybrid of Delta and Omicron, known as ‘Deltacron’, has been identified in France, Denmark and the Netherlands

53
article thumbnail

FDA says no to AZ’s Fasenra for nasal polyp indication

pharmaphorum

AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic rhinosinusitis in people with nasal polyps, after the FDA rejected its marketing application. The US regulator has asked for additional clinical data, according to AZ, which said it remains committed to brining the drug to patients with the inflammatory condition, which results in the growth of nasal polyps in the nose that can sometimes require surgical intervention.

FDA 116
article thumbnail

Oracle: How can clinical trials better fill the patient inclusivity gap?

Outsourcing Pharma

While strides have been made recruiting more representative patient populations, more can and should be done, according to an Oracle Health Sciences leader.

97
article thumbnail

Sisram Medical Ltd Announces 2021 Record Annual Results

Pharma Mirror

HONG KONG, Sisram Medical Ltd (the “Company” or “Sisram”, stock code: 1696.HK; together with its subsidiaries referred as the “Group”), a global consumer wellness group, featuring a never-before-seen synergistic ecosystem of business building blocks and consumer-focused branding, ranging from medical aesthetics capital equipment, via injectables therapy, aesthetic dentistry, personal care and more, today announced its audited consolidated annual results for th

52
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

What’s Cooking? : A Taste from Around the World

Tria Health Blog

The theme for National Nutrition Month is “Celebrate a World of Flavors”. With that in mind, we wanted to provide healthy recipes from other cultures that you can make in celebration of this month.

52
article thumbnail

Does COVID-19 infection raise the risk of diabetes?

pharmaphorum

Researchers in Germany are have found a possible link between mild COVID-19 infection and an increased risk of type 2 diabetes, although they caution the signal needs further investigation. The team from Heinrich Heine University in Dusseldorf and healthcare data science company IQVIA identified the possible correlation after analysing health records from 8.8 million patients registered at 1,171 health practices across Germany, including almost 36,000 who had been diagnosed with mild COVID-19.

Hospitals 114
article thumbnail

Praxis: ‘No quick fix’ for increasing clinical trial inclusivity

Outsourcing Pharma

A leader from the patient recruitment specialist discusses the industryâs ongoing challenges with patient population diversity, and potential solutions.

85
article thumbnail

Top Medical School Scholarships to Apply to in 2022

Board Vitals - Pharmacist

There’s no way around it, medical school is expensive and unfortunately for medical students, the costs have been increasing over the past several years. According to the Association of American Medical Colleges , the average cost of medical school including tuition, fees, and health insurance for first-year students attending in-state public schools in 2021-2022 was $39,237, a 29% increase from the cost in 2012-13 ($30,192).

article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

How Pharmacy Students Can Advocate for Pharmacist Prescribing of Hormonal Contraception

Birth Control Pharmacist

Can pharmacy students advocate for pharmacists prescribing hormonal contraceptives? YES, that is exactly what Wilson Pace , a graduate of the University of Utah College of Pharmacy did. When Wilson heard about the barriers and costs that women experience when accessing contraceptives. His perseverance and dedication to advocacy as a pharmacy student allowed him to take action in his leadership class.

52
article thumbnail

Pharma group seeks digital measure standards for Alzheimer’s

pharmaphorum

A group of pharma companies and academic groups have joined forces with the Digital Medicine Society (DiMe) to develop standardised, digital clinical measures that can be used in the development of therapies for Alzheimer’s disease and related dementias. According to the consortium – which includes drugmakers Biogen, Eisai, Eli Lilly and Merck & Co – there is a lack of measures that can be used to determine whether new therapies for Alzheimer’s are actually working.

111
111
article thumbnail

AARDEX to monitor adherence in patients with PTSD, neurodegenerative diseases

Outsourcing Pharma

The medication adherence specialist is joining IT4Anxiety, a project focused on dealing with anxiety in patients with mental disorders, via technology.

59
article thumbnail

PMN HCP Engagement Summit

Pharma Marketing Network

Tune in and watch the Pharma Marketing Network and industry experts from Novo Nordisk, Eisai, GSK, Otsuka, and more during part 1 of a 2 part series on engagement. This PMN HCP Engagement Summit focused HCP Engagement throughout the following panels: Modular Content: Making It Work. Get insights for pharma marketing insiders on restructuring your content strategy allowing more flexibility and agility to deliver more relative content to your customers.

52
article thumbnail

How Pharmacy Students Can Advocate for Pharmacist Prescribing of Hormonal Contraception?

Birth Control Pharmacist

Can pharmacy students advocate for pharmacists prescribing hormonal contraceptives? YES, that is exactly what Wilson Pace , a graduate of the University of Utah College of Pharmacy did. When Wilson heard about the barriers and costs that women experience when accessing contraceptives. His perseverance and dedication to advocacy as a pharmacy student allowed him to take action in his leadership class.

52
article thumbnail

Disrupted medical conferences: Lessons learnt

pharmaphorum

The new normal is already here. Get used to it. The COVID-19 pandemic has radically disrupted traditional medical society conferences in a way that could scarcely have been imagined in 2019. The vast majority of societies were able to transition their planned physical events to virtual formats within remarkably short periods of time, and some delivered impressive attendee experiences.

Labelling 105
article thumbnail

Tech Innovations: March 2022

Outsourcing Pharma

The latest news on software, manufacturing solutions, partnerships, and more includes IQVIA, TFF Pharmaceuticals, Quotient Sciences and other key companies.

52
article thumbnail

Biopharmaceutical Excipient Manufacturing – Current Scenario and Future Trends

Roots Analysis

Over the years, the rising popularity of biologics has led to a paradigm shift in the healthcare industry. In the last decade alone, the annual number of approvals of biopharmaceuticals (including monoclonal antibodies, recombinant proteins, vaccines and gene therapies), by the US FDA, have steadily risen. In fact, over 8,000 biological pharmaceutical products are currently under clinical investigation worldwide.

article thumbnail

COVID-19 infections seeing spike across UK

Pharma Times

In the coming months, an additional vaccine booster will be offered to those over 75, care home residents and to those over 12 who are most vulnerable

article thumbnail

Sandoz bulks up ahead of possible sale with Coalesce buy

pharmaphorum

Novartis may be planning to sell off its generics business Sandoz, but that hasn’t stopped it investing in the unit ahead of a decision on its future later this year. This morning, Sandoz announced it has acquired medical and drug delivery device specialist Coalesce Product Development, bolstering its capabilities for the development of respiratory medicines and ‘complex’ generics.

article thumbnail

Diverse site staff better fits inclusive patient population: Inato

Outsourcing Pharma

A leader from the trial platform company discusses how patient experience can be enhanced when the clinical trial team shares a background with the subjects.

52
article thumbnail

Cannabinoid Hyperemesis Syndrome (CHS)

Pharmacy Friday Pearls

Download PDF. Introduction . 1. Commonly identified as symptoms, including nausea, cyclic vomiting and abdominal pain, that are refractory to available antiemetics and analgesics. 2. Patients tend to take compulsive hot baths/showers for symptom relief. 3. Characteristically distinguished from cyclic vomiting syndrome, these symptoms are usually preceded by years of chronic cannabis use and symptoms are typically resolved with cessation of cannabis use. 4.

40
article thumbnail

NICE to improve diagnosis for foetal alcohol spectrum disorder

Pharma Times

Better treatment for conditions experienced by individuals who were exposed to alcohol before birth

46
article thumbnail

Akili hires gaming guru Jon David as chief product officer

pharmaphorum

Gaming industry veteran Jon David, responsible for highly-downloaded mobile games, including the Bejeweled and Plants vs Zombies franchises, has moved into the digital health arena by taking a senior position at Akili Interactive Labs. As Akili’s chief product officer, his role will be to make sure that the company’s game-based therapies are as engaging as “high-end entertainment,” ensuring that they are fun to play, as well as therapeutically effective.

FDA 98
article thumbnail

AbbVie, Gedeon Richter to partner on developing neuropsychiatric drugs

Outsourcing Pharma

The US- and Hungary-based pharma firms will work on research, development, and commercialization of dopamine receptor modulators for potential treatments.

52